Treatment of Knee Osteoarthritis and Chondral Injury with Umbilical Cord/Wharton’s Jelly-Derived Mesenchymal Stem Cells: A Systematic Review of Safety and Efficacy
Source abstract
Abstract
Knee osteoarthritis (KOA) is a major cause of pain and disability worldwide, with no current treatment modality able to prevent the progressive destruction of articular cartilage. Mesenchymal stem cells (MSCs) have attracted interest in treating KOA and cartilage injury due to their self-renewal and multidirectional differentiation potential, as well as local bioactive factors with immunomodulatory and regenerative potential. This study aimed to evaluate the currently available studies using the intra-articular injection of Wharton’s jelly MSCs for KOA and cartilage injury. We analyzed all clinical trials published from inception to 31 December 2023. Six studies met the inclusion criteria, for a total of 97 patients and 134 knees. The follow-up period ranged from 3 to 48 months. There were no serious adverse effects noted. There was significant improvement in functional outcomes in the form of VAS, WOMAC, KOOS, and IKDC parameters, though radiological outcomes demonstrated mixed results. In conclusion, patients with KOA treated with intra-articular injections of Wharton’s jelly MSCs showed improvements in functional outcomes with no severe adverse effects. Multiple injections of Wharton’s jelly MSCs showed better outcomes compared to single-injection techniques. Wharton’s jelly MSCs may have potential as a cornerstone in the future treatment of KOA.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Mesenchymal stem cell research · Osteoarthritis Treatment and Mechanisms · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopaedic and Traumatology, Faculty of Medicine, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia
Pharmacoepidemiology and Drug Safety Unit, Department of Pharmacology, Faculty of Medicine, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia
Cell Therapy Center, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia
References (24)
Show source-provided references
1. Developments in the scientific understanding of osteoarthritis10.1186/ar2655 ↗
2. Osteoarthritis10.1016/S0140-6736(97)07226-7 ↗
3. Osteoarthritis10.1038/nrdp.2016.72 ↗
4. Roseti, L., Desando, G., Cavallo, C., Petretta, M., and Grigolo, B. (2019). Articular Cartilage Regeneration in Osteoarthritis. Cells, 8.10.3390/cells8111305 ↗
5. AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition
6. Knee osteoarthritis: Pathophysiology and current treatment modalities10.2147/JPR.S154002 ↗
7. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees10.1053/joca.2001.0504 ↗
8. Stem cell injections for osteoarthritis of the knee
9. Umbilical Cord as Prospective Source for Mesenchymal Stem Cell-Based Therapy10.1155/2016/6901286 ↗
10. Ultrasound-guided intra-articular injection of expanded umbilical cord mesenchymal stem cells in knee osteoarthritis: A safety/efficacy study with MRI data10.2217/rme-2021-0121 ↗
11. Umbilical cord-derived mesenchymal stem cells for treating osteoarthritis of the knee: A single-arm, open-label study10.1007/s00590-020-02630-5 ↗
12. Assessment of clinical, biochemical, and radiological outcomes following intra-articular injection of Wharton jelly-derived mesenchymal stromal cells in patients with knee osteoarthritis: A prospective clinical study10.1097/MD.0000000000030628 ↗
13. Ao, Y., Duan, J., Xiong, N., Qian, N., Zhang, R., Yang, L., Yu, S., and Wang, F. (2023). Repeated intra-articular injections of umbilical cord-derived mesenchymal stem cells for knee osteoarthritis: A phase I, single-arm study. BMC Musculoskelet. Disord., 24.10.1186/s12891-023-06555-y ↗
14. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial10.1002/sctm.18-0053 ↗
15. Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: A pilot study10.1016/j.jcyt.2018.11.003 ↗
16. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement10.1080/14653240600855905 ↗
17. Efficacy and safety of mesenchymal stem cell injections for patients with osteoarthritis: A meta-analysis and review of RCTs10.1007/s00402-020-03703-0 ↗
18. Does the Source of Mesenchymal Stem Cell Have an Effect in the Management of Osteoarthritis of the Knee? Meta-Analysis of Randomized Controlled Trials10.1177/1947603520951623 ↗
19. Allogeneic Mesenchymal Stem Cells Stimulate Cartilage Regeneration and Are Safe for Single-Stage Cartilage Repair in Humans upon Mixture with Recycled Autologous Chondrons10.1002/stem.2475 ↗
20. Efficacy of mesenchymal stromal cells for the treatment of knee osteoarthritis: A meta-analysis of randomized controlled trials10.1186/s13018-020-02128-0 ↗
21. Injective mesenchymal stem cell-based treatments for knee osteoarthritis: From mechanisms of action to current clinical evidences10.1007/s00167-018-5118-9 ↗
22. Which is the most effective one in knee osteoarthritis treatment from mesenchymal stem cells obtained from different sources?—A systematic review with conventional and network meta-analyses of randomized controlled trials10.21037/atm-20-5116 ↗
23. Clinical application of mesenchymal stem cell in regenerative medicine: A narrative review10.1186/s13287-022-03054-0 ↗
24. Mesenchymal Stem Cells: Time to Change the Name!10.1002/sctm.17-0051 ↗